REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Coherus Oncology, Inc. (CHRS) on Monday reported a loss of $37.6 million in its fourth quarter.
The Redwood City, California-based company said it had a loss of 31 cents per share. Losses, adjusted for one-time gains and costs, came to 34 cents per share.
The drug developer posted revenue of $12.7 million in the period, which fell short of Street forecasts. Three analysts surveyed by Zacks expected $13.1 million.
For the year, the company reported profit of $168 million, or $1.43 per share. Revenue was reported as $42.2 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CHRS at https://www.zacks.com/ap/CHRS
/Oracle%20Corp_%20office%20logo-by%20Mesut%20Dogan%20via%20iStock.jpg)
/An%20image%20of%20a%20Tesla%20humanoid%20robot%20in%20front%20of%20the%20company%20logo%20Around%20the%20World%20Photos%20via%20Shutterstock.jpg)
/A%20Palantir%20office%20building%20in%20Tokyo_%20Image%20by%20Hiroshi-Mori-Stock%20via%20Shutterstock_.jpg)